|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|
| Revenues | ||
| Cost of sales | ||
| Gross profit | ||
| Operating expenses | ||
| Selling, general and administrative expenses | ||
| Research and product development expenses | ||
| Total operating expenses | ||
| Loss from operations | ||
| Loss from joint ventures | ||
| Finance income (loss) | ||
| Interest expense, net on financial instruments measured at amortized cost | ||
| Foreign currency gains net | ||
| Other finance gains (losses), net | ||
| Finance loss, net | ||
| Loss before income taxes | ||
| Income tax expense | ||
| Net loss for the year | ||
| Items that will not be reclassified subsequently to net loss: | ||
| Re-measurement of actuarial liability | ||
| Items that may be reclassified subsequently to net loss | ||
| Exchange differences on translating foreign operations | ||
| Comprehensive loss for the year | ||
| Net loss per share | ||
| Basic and diluted | ||
| Weighted average number of common shares outstanding |
Loading...
